As of 2025-08-23, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 77.79 USD. This relative valuation is based on P/E multiples. With the latest stock price at 135.43 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -42.6%.
The range of the Relative Valuation is 60.60 - 111.88 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 21.2x | 18.4x |
| Forward P/E multiples | 19.8x - 27.6x | 22.5x |
| Fair Price | 60.60 - 111.88 | 77.79 |
| Upside | -55.3% - -17.4% | -42.6% |
| Date | P/E |
| 2025-08-22 | 38.48 |
| 2025-08-21 | 38.44 |
| 2025-08-20 | 37.86 |
| 2025-08-19 | 37.74 |
| 2025-08-18 | 37.83 |
| 2025-08-15 | 37.76 |
| 2025-08-14 | 37.31 |
| 2025-08-13 | 37.40 |
| 2025-08-12 | 36.62 |
| 2025-08-11 | 35.23 |
| 2025-08-08 | 35.52 |
| 2025-08-07 | 35.69 |
| 2025-08-06 | 36.49 |
| 2025-08-05 | 36.48 |
| 2025-08-04 | 36.38 |
| 2025-08-01 | 36.63 |
| 2025-07-31 | 36.44 |
| 2025-07-30 | 38.86 |
| 2025-07-29 | 38.13 |
| 2025-07-28 | 37.99 |
| 2025-07-25 | 37.55 |
| 2025-07-24 | 37.41 |
| 2025-07-23 | 37.98 |
| 2025-07-22 | 37.72 |
| 2025-07-21 | 37.46 |
| 2025-07-18 | 37.51 |
| 2025-07-17 | 38.11 |
| 2025-07-16 | 37.93 |
| 2025-07-15 | 37.29 |
| 2025-07-14 | 38.40 |
| 2025-07-11 | 37.92 |
| 2025-07-10 | 38.34 |
| 2025-07-09 | 37.94 |
| 2025-07-08 | 36.58 |
| 2025-07-07 | 36.34 |
| 2025-07-03 | 36.69 |
| 2025-07-02 | 36.77 |
| 2025-07-01 | 36.37 |
| 2025-06-30 | 35.72 |
| 2025-06-27 | 35.64 |
| 2025-06-26 | 36.00 |
| 2025-06-25 | 36.31 |
| 2025-06-24 | 36.42 |
| 2025-06-23 | 35.75 |
| 2025-06-20 | 35.96 |
| 2025-06-18 | 36.18 |
| 2025-06-17 | 35.48 |
| 2025-06-16 | 35.52 |
| 2025-06-13 | 35.35 |
| 2025-06-12 | 35.52 |